Company intelligence / Profile preview

MATICO

Ownership: Private
Development stage: Other

Overview

Matica Biotechnology provides end-to-end viral vector and gene therapy manufacturing services, supporting over 300 vector projects, more than 36 cell therapy projects, over 20 IND filings, and five BLA project filings. It operates a purpose-built cGMP facility with advanced technology platforms to accelerate client programs from development through commercialization.

Modalities: Viral vectorGene therapyCell therapy
Industry: Contract Manufacturing Organization

Partnerships

Texas A&M National Center for Therapeutics Manufacturing

Beyond the preview

Go deeper on MATICO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MATICO.

Explore the full profile